TIBER CREEK GROUP for GILEAD SCIENCES, INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Issues related to intellectual property protections for COVID-19 vaccines and treatments.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| COREY MALMGREN | — |
Health Issues HCR
Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169). Issues related to HIV.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| BRYANT HALL | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
Medicare/Medicaid MMM
Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| BRYANT HALL | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
Natural Resources NAT
Issues relating to the importation of non-human primates.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHON JONES | — |
Budget/Appropriations BUD
Issues related to FY2024 appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LEFFINGWELL New | Mbr Servs & Coalitions Dir., House Approps Cmte (2016-2017); CoS, Rep. Kay Granger (2012-2015); Dep CoS, Rep. Granger (2010-2012); Comms Dir, Rep. Granger (2009-2010); Press Sec, Rep. Jon Porter (2007-2009); Projects Dir, Rep. Mark Kirk (2006-2007) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.